Serum Levels of Anti-Citrullinated Protein Antibody (ACPA) and TWEAK in Patients with Rheumatoid Arthritis: Association with Disease Activity and Treatment Modalities


Creative Commons License

KARKUCAK M. , ÇAPKIN E. , Cakirbay H., Akyuz A., ALVER A. , CANSU A. , ...Daha Fazla

TURKISH JOURNAL OF RHEUMATOLOGY, cilt.26, ss.204-209, 2011 (SCI İndekslerine Giren Dergi) identifier identifier

  • Cilt numarası: 26 Konu: 3
  • Basım Tarihi: 2011
  • Doi Numarası: 10.5606/tjr.2011.032
  • Dergi Adı: TURKISH JOURNAL OF RHEUMATOLOGY
  • Sayfa Sayıları: ss.204-209

Özet

Objectives: In this study, we evaluated the serum levels of a serum TNF-related weak inducer of apoptosis (TWEAK) and anti-citrullinated protein antibody (ACPA) and investigated the possible correlation of these parameters with disease activity, cytokine levels and anti-TNF-alpha treatment in patients with rheumatoid arthritis (RA).